Searched for
PATIENT DATA MANAGEMENT
ET Most Innovative AI Product Awards 2026: Why healthcare has become the ultimate test for AI innovationET Most Innovative AI Product Awards 2026 acknowledges AI products that are altering the medical field with faster, smarter and improved di...- More sleep means good health? Answer is... Study says people with diabetes face risk of developing deadly liver disease with rise in nap timeMore sleep means good health? Answer is no. Study says people with diabetes face risk of developing deadly liver disease with rise in nap t...
- Forget chatbots, Ambani's Reliance wants to own India's entire AI economyReliance Industries is charting a unique AI strategy, aiming to democratise artificial intelligence in India by focusing on affordability a...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...
- Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Public-private projects key to expand access to Kidney care: NephroPlusNephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-b...
- Just donate blood and get VIP into famous temple. The result is blood bank surplus at local hospitalsA unique program in Madhya Pradesh connects blood donation with VIP darshan at Omkareshwar Jyotirlinga temple. Devotees donating blood rece...
- AI is everywhere. But which products are truly transforming business?The next wave of business transformation is being driven by AI products that deliver measurable results. The ET Most Innovative AI Product ...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Hair loss due to soft drinks: Hair transplant surgeon explains whether drinking soda with meals can make you go baldCold drink causing hair loss: Daily cold drink habits might affect hair health. Doctors note a link between sugary beverages and conditions...
- Customer service no longer a cost centre in AI era: HGS CEO Venkatesh KorlaArtificial intelligence is transforming the business process management sector. Companies are now prioritizing customer experience, moving ...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- UK reviewing Palantir's NHS contract amid pressure to use break clauseBritain is reviewing a major contract with American firm Palantir for the National Health Service. The government must decide by early 2027...
- World's most contagious disease detected in California wastewater: Key signs of virus and symptoms you should watchMeasles outbreak: California health officials are alarmed by the detection of measles in wastewater, coinciding with the state's worst outb...
- Indian market at 11% discount to long-term average; Anshul Saigal says it's a buyer's market for 3–5 year investorsMarket confusion presents a rare chance for patient investors. Anshul Saigal believes current valuations offer significant gains for those ...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
Load More
